Featured News
Micron Biomedical Extends Series A Financing to 33+ Million to Accelerate Commercialization of Needle-Free Therapeutics and Vaccines
January 16, 2025
Micron Biomedical Wins $2 Million BARDA Competition for Its Collaboration with Zipcode Bio to Develop mRNA-Based Broad Protecting Flu Vaccine Without Needles
January 14, 2025
CEPI and Micron Biomedical Accelerate Needle-Free Vaccines against Disease X with $3.7 Million Grant to Advance Learnings from COVID-19
January 8, 2025
Micron Biomedical Secures $43 Million in Total Grant Support to Improve Coverage of Measles and Rubella Vaccine and Accelerate World’s First Phase 2 Trial of Needle-Free Drug and Vaccine Technology in Infants
January 7, 2025
Micron Biomedical Recognized as a Breakthrough Scientific Innovation in the Prix Galien Start-Up Category
November 7, 2024
Micron Biomedical Wins the “Biotech Medical Innovation” Award at Boston Biotech Week
October 17, 2024

No Needles. Many Appli­cations.
Micron Biomedical delivers traditionally injected vaccines and medicines without needles through a proprietary dissolvable microarray technology.
Anytime, Anywhere Access
Micron’s clinical-stage technology offers access to life-saving pharmaceuticals for children and adults and allows painless, self-administration of therapeutics and vaccines, in seconds to minutes—at home, in the field, and wherever they are needed—all with the touch of a button.


Breaking infra­structure barriers
Micron is solving some of the most pressing challenges facing conventional vaccine and drug administration by eliminating or greatly reducing the need for cold chain during delivery and/or storage; reducing transportation and storage costs; allowing safe vaccine and drug administration by non-medical personnel; reducing medical waste; and offering needle-free solutions to address vaccine hesitancy and improve patient compliance.
“I’m determined to continue to break down the barriers to global vaccine access, and that’s why I’m thrilled to be part of Micron Biomedical.”
Dr. Seth Berkley
Scientific Advisor, Micron Biomedical
“You don’t need a trained healthcare worker to administer the vaccine. You eliminate the fear factor, the risk of blood and body fluids from the needle. For the person administering it, you don’t have medical waste like you do with a syringe and needle.”